Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin and tizanidine for pain and anxiety after cataract surgery
IRCT20190528043737N3Phase 2Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of melatonin and tizanidine in cataract, sponsored by Hormozgan University of Medical Sciences. Primary endpoints: Postoperative pain intensity and Postoperative anxiety. Started Dec 2022; status: completed.
02
Drugs
melatonintizanidine
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20190528043737N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190528043737N3.